Sepsis affects approximately 30 million worldwide, meaning it is crucial that effective and affordable management techniques – that don’t facilitate the rise in antimicrobial resistance – are found. This article assesses the burden of sepsis on the US healthcare system and starts to assess the usefulness of pancreatic stone protein (PSP) as a promising biomarker in the early detection of the disease. Read more here.